-
1
-
-
0035124911
-
Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance
-
Bosio P.M., et al. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 2001, 184(2):146-152.
-
(2001)
Am J Obstet Gynecol
, vol.184
, Issue.2
, pp. 146-152
-
-
Bosio, P.M.1
-
2
-
-
0037699954
-
The biology of VEGF and its receptors
-
Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9(6):669-676.
-
(2003)
Nat Med
, vol.9
, Issue.6
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.P.2
LeCouter, J.3
-
3
-
-
33344467123
-
VEGF function in vascular pathogenesis
-
Ng Y.S., Krilleke D., Shima D.T. VEGF function in vascular pathogenesis. Exp Cell Res 2006, 312(5):527-537.
-
(2006)
Exp Cell Res
, vol.312
, Issue.5
, pp. 527-537
-
-
Ng, Y.S.1
Krilleke, D.2
Shima, D.T.3
-
4
-
-
84921266771
-
Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells
-
Reynolds J.A., et al. Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells. Pharmacol Ther 2013.
-
(2013)
Pharmacol Ther
-
-
Reynolds, J.A.1
-
5
-
-
34548443831
-
Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition
-
Holmes K., et al. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007, 19(10):2003-2012.
-
(2007)
Cell Signal
, vol.19
, Issue.10
, pp. 2003-2012
-
-
Holmes, K.1
-
6
-
-
35748983824
-
Roles for VEGF in the adult
-
Maharaj A.S., D'Amore P.A. Roles for VEGF in the adult. Microvasc Res 2007, 74(2-3):100-113.
-
(2007)
Microvasc Res
, vol.74
, Issue.2-3
, pp. 100-113
-
-
Maharaj, A.S.1
D'Amore, P.A.2
-
7
-
-
0035167615
-
Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies
-
List A.F. Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. Oncologist 2001, 6(Suppl: 5):24-31.
-
(2001)
Oncologist
, vol.6
, pp. 24-31
-
-
List, A.F.1
-
8
-
-
0034000338
-
Prognostic value of vascular endothelial growth factor in breast cancer
-
Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000, 5(Suppl: 1):37-44.
-
(2000)
Oncologist
, vol.5
, pp. 37-44
-
-
Gasparini, G.1
-
9
-
-
0031737424
-
MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas
-
Zietz C., et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol 1998, 153(5):1425-1433.
-
(1998)
Am J Pathol
, vol.153
, Issue.5
, pp. 1425-1433
-
-
Zietz, C.1
-
11
-
-
84869869502
-
The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells
-
Albrecht-Schgoer K., et al. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation 2012, 126(21):2491-2501.
-
(2012)
Circulation
, vol.126
, Issue.21
, pp. 2491-2501
-
-
Albrecht-Schgoer, K.1
-
12
-
-
84862768329
-
Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms
-
Finley S.D., Popel A.S. Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms. AAPS J 2012, 14(3):500-509.
-
(2012)
AAPS J
, vol.14
, Issue.3
, pp. 500-509
-
-
Finley, S.D.1
Popel, A.S.2
-
13
-
-
0035062394
-
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
-
Robinson C.J., Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001, 114(Pt 5):853-865.
-
(2001)
J Cell Sci
, vol.114
, pp. 853-865
-
-
Robinson, C.J.1
Stringer, S.E.2
-
14
-
-
0032907687
-
Vascular endothelial growth factor (VEGF) and its receptors
-
Neufeld G., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J: Official Publ Fed Am Soc Exp Biol 1999, 13(1):9-22.
-
(1999)
FASEB J: Official Publ Fed Am Soc Exp Biol
, vol.13
, Issue.1
, pp. 9-22
-
-
Neufeld, G.1
-
15
-
-
14044271973
-
Transcriptional regulation of vascular endothelial growth factor in cancer
-
Loureiro R.M., D'Amore P.A. Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev 2005, 16(1):77-89.
-
(2005)
Cytokine Growth Factor Rev
, vol.16
, Issue.1
, pp. 77-89
-
-
Loureiro, R.M.1
D'Amore, P.A.2
-
16
-
-
0029761644
-
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
-
Forsythe J.A., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16(9):4604-4613.
-
(1996)
Mol Cell Biol
, vol.16
, Issue.9
, pp. 4604-4613
-
-
Forsythe, J.A.1
-
17
-
-
2942616541
-
RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells
-
Shie J.L., et al. RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem 2004, 279(24):25010-25016.
-
(2004)
J Biol Chem
, vol.279
, Issue.24
, pp. 25010-25016
-
-
Shie, J.L.1
-
18
-
-
41549105367
-
Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism
-
Crisostomo P.R., et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008, 294(3):C675-C682.
-
(2008)
Am J Physiol Cell Physiol
, vol.294
, Issue.3
, pp. C675-C682
-
-
Crisostomo, P.R.1
-
19
-
-
0031974158
-
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
-
Murohara T., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998, 97(1):99-107.
-
(1998)
Circulation
, vol.97
, Issue.1
, pp. 99-107
-
-
Murohara, T.1
-
20
-
-
0036331674
-
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans
-
Eppler S.M., et al. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther 2002, 72(1):20-32.
-
(2002)
Clin Pharmacol Ther
, vol.72
, Issue.1
, pp. 20-32
-
-
Eppler, S.M.1
-
21
-
-
53549094683
-
A compartment model of VEGF distribution in blood, healthy and diseased tissues
-
Stefanini M.O., et al. A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol 2008, 2:77.
-
(2008)
BMC Syst Biol
, vol.2
, pp. 77
-
-
Stefanini, M.O.1
-
23
-
-
84884189971
-
Fcgamma receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies
-
Justiniano S.E., et al. Fcgamma receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J Biol Chem 2013, 288(37):26800-26809.
-
(2013)
J Biol Chem
, vol.288
, Issue.37
, pp. 26800-26809
-
-
Justiniano, S.E.1
-
24
-
-
11144297756
-
Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice
-
Hiratsuka S., et al. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol 2005, 25(1):346-354.
-
(2005)
Mol Cell Biol
, vol.25
, Issue.1
, pp. 346-354
-
-
Hiratsuka, S.1
-
25
-
-
0030751493
-
Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
-
Gerber H.P., et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997, 272(38):23659-23667.
-
(1997)
J Biol Chem
, vol.272
, Issue.38
, pp. 23659-23667
-
-
Gerber, H.P.1
-
26
-
-
0029758798
-
Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
-
Waltenberger J., et al. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 1996, 94(7):1647-1654.
-
(1996)
Circulation
, vol.94
, Issue.7
, pp. 1647-1654
-
-
Waltenberger, J.1
-
27
-
-
0030609013
-
Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
-
Barleon B., et al. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 1997, 57(23):5421-5425.
-
(1997)
Cancer Res
, vol.57
, Issue.23
, pp. 5421-5425
-
-
Barleon, B.1
-
28
-
-
0030600969
-
VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane
-
Wilting J., et al. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev Biol 1996, 176(1):76-85.
-
(1996)
Dev Biol
, vol.176
, Issue.1
, pp. 76-85
-
-
Wilting, J.1
-
29
-
-
84871611836
-
FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update
-
Gordon K., et al. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. Hum Mutat 2013, 34(1):23-31.
-
(2013)
Hum Mutat
, vol.34
, Issue.1
, pp. 23-31
-
-
Gordon, K.1
-
30
-
-
0033522927
-
Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner
-
Fujio Y., Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 1999, 274(23):16349-16354.
-
(1999)
J Biol Chem
, vol.274
, Issue.23
, pp. 16349-16354
-
-
Fujio, Y.1
Walsh, K.2
-
31
-
-
33646107369
-
VEGF receptor signalling - in control of vascular function
-
Olsson A.K., et al. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006, 7(5):359-371.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, Issue.5
, pp. 359-371
-
-
Olsson, A.K.1
-
32
-
-
0032557564
-
Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
-
Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998, 273(21):13313-13316.
-
(1998)
J Biol Chem
, vol.273
, Issue.21
, pp. 13313-13316
-
-
Gerber, H.P.1
Dixit, V.2
Ferrara, N.3
-
33
-
-
0035174001
-
The role of FGF and VEGF in angioblast induction and migration during vascular development
-
Poole T.J., Finkelstein E.B., Cox C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn: Official Pub Am Assoc Anatomists 2001, 220(1):1-17.
-
(2001)
Dev Dyn: Official Pub Am Assoc Anatomists
, vol.220
, Issue.1
, pp. 1-17
-
-
Poole, T.J.1
Finkelstein, E.B.2
Cox, C.M.3
-
34
-
-
0033566938
-
Multiple developmental roles of VEGF suggested by a LacZ-tagged allele
-
Miquerol L., et al. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev Biol 1999, 212(2):307-322.
-
(1999)
Dev Biol
, vol.212
, Issue.2
, pp. 307-322
-
-
Miquerol, L.1
-
35
-
-
84888303236
-
Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid
-
Kim A., et al. Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta 2013, 34(10):873-878.
-
(2013)
Placenta
, vol.34
, Issue.10
, pp. 873-878
-
-
Kim, A.1
-
36
-
-
34250029921
-
Genetic polymorphisms for vascular endothelial growth factor in perinatal complications
-
Banyasz I., et al. Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. Eur Cytokine Network 2006, 17(4):266-270.
-
(2006)
Eur Cytokine Network
, vol.17
, Issue.4
, pp. 266-270
-
-
Banyasz, I.1
-
37
-
-
84884578824
-
Chronic morbidities of premature newborns
-
Balla G., Szabo M. Chronic morbidities of premature newborns. Orv Hetil 2013, 154(38):1498-1511.
-
(2013)
Orv Hetil
, vol.154
, Issue.38
, pp. 1498-1511
-
-
Balla, G.1
Szabo, M.2
-
38
-
-
17444391278
-
Vascular endothelial growth factor in preterm infants with respiratory distress syndrome
-
Tsao P.N., et al. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome. Pediatr Pulmonol 2005, 39(5):461-465.
-
(2005)
Pediatr Pulmonol
, vol.39
, Issue.5
, pp. 461-465
-
-
Tsao, P.N.1
-
39
-
-
84894432213
-
Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study
-
Voller S.B., et al. Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study. Early Human Dev 2014, 90(4):195-200.
-
(2014)
Early Human Dev
, vol.90
, Issue.4
, pp. 195-200
-
-
Voller, S.B.1
-
40
-
-
79955115575
-
In vivo monitoring of fetoplacental VEGFR2 gene activity in a murine pregnancy model using a VEGFR2-luc reporter gene and bioluminescent imaging
-
Greene J.M., et al. In vivo monitoring of fetoplacental VEGFR2 gene activity in a murine pregnancy model using a VEGFR2-luc reporter gene and bioluminescent imaging. Reprod Biol Endocrinol: RB&E 2011, 9:51.
-
(2011)
Reprod Biol Endocrinol: RB&E
, vol.9
, pp. 51
-
-
Greene, J.M.1
-
41
-
-
0025669875
-
Breast milk and neonatal necrotising enterocolitis
-
Lucas A., Cole T.J. Breast milk and neonatal necrotising enterocolitis. Lancet 1990, 336(8730):1519-1523.
-
(1990)
Lancet
, vol.336
, Issue.8730
, pp. 1519-1523
-
-
Lucas, A.1
Cole, T.J.2
-
42
-
-
0032955187
-
Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells
-
Siafakas C.G., et al. Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res 1999, 45(5 Pt 1):652-657.
-
(1999)
Pediatr Res
, vol.45
, Issue.5
, pp. 652-657
-
-
Siafakas, C.G.1
-
43
-
-
84862492014
-
Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance
-
Patki S., et al. Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance. Cytokine 2012, 59(2):305-308.
-
(2012)
Cytokine
, vol.59
, Issue.2
, pp. 305-308
-
-
Patki, S.1
-
44
-
-
0031889548
-
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology
-
Banks R.E., et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998, 77(6):956-964.
-
(1998)
Br J Cancer
, vol.77
, Issue.6
, pp. 956-964
-
-
Banks, R.E.1
-
45
-
-
64849116779
-
The role of vascular endothelial growth factor in wound healing
-
Bao P., et al. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009, 153(2):347-358.
-
(2009)
J Surg Res
, vol.153
, Issue.2
, pp. 347-358
-
-
Bao, P.1
-
46
-
-
80051800928
-
VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study)
-
Adas G., et al. VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study). Int J Surg 2011, 9(6):467-471.
-
(2011)
Int J Surg
, vol.9
, Issue.6
, pp. 467-471
-
-
Adas, G.1
-
49
-
-
0033860607
-
Is human fracture hematoma inherently angiogenic?
-
Street J., et al. Is human fracture hematoma inherently angiogenic?. Clin Orthop Relat Res 2000, 378:224-237.
-
(2000)
Clin Orthop Relat Res
, vol.378
, pp. 224-237
-
-
Street, J.1
-
50
-
-
0037162547
-
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover
-
Street J., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002, 99(15):9656-9661.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, Issue.15
, pp. 9656-9661
-
-
Street, J.1
-
51
-
-
0032965317
-
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
-
Rivard A., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999, 154(2):355-363.
-
(1999)
Am J Pathol
, vol.154
, Issue.2
, pp. 355-363
-
-
Rivard, A.1
-
52
-
-
0031714785
-
Increased plasma vascular endothelial growth factor among patients with chronic venous disease
-
Shoab S.S., Scurr J.H., Coleridge-Smith P.D. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg 1998, 28(3):535-540.
-
(1998)
J Vasc Surg
, vol.28
, Issue.3
, pp. 535-540
-
-
Shoab, S.S.1
Scurr, J.H.2
Coleridge-Smith, P.D.3
-
53
-
-
0030724190
-
Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury
-
Luo Z., et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thoracic Surg 1997, 64(4):993-998.
-
(1997)
Ann Thoracic Surg
, vol.64
, Issue.4
, pp. 993-998
-
-
Luo, Z.1
-
54
-
-
0032578961
-
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
-
Losordo D.W., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998, 98(25):2800-2804.
-
(1998)
Circulation
, vol.98
, Issue.25
, pp. 2800-2804
-
-
Losordo, D.W.1
-
55
-
-
0033503798
-
Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
-
[discussion 470-2]
-
Rosengart T.K., et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999, 230(4):466-470. [discussion 470-2].
-
(1999)
Ann Surg
, vol.230
, Issue.4
, pp. 466-470
-
-
Rosengart, T.K.1
-
56
-
-
84895734499
-
VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
-
Kivela R., et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med 2014, 6(3):307-321.
-
(2014)
EMBO Mol Med
, vol.6
, Issue.3
, pp. 307-321
-
-
Kivela, R.1
-
57
-
-
84896318095
-
Cardioprotective effect of VEGF and venom VEGF-like protein in acute myocardial ischemia in mice: effect on mitochondrial function
-
Messadi E., et al. Cardioprotective effect of VEGF and venom VEGF-like protein in acute myocardial ischemia in mice: effect on mitochondrial function. J Cardiovasc Pharmacol 2014, 63(3):274-281.
-
(2014)
J Cardiovasc Pharmacol
, vol.63
, Issue.3
, pp. 274-281
-
-
Messadi, E.1
-
58
-
-
84896710527
-
The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis
-
Karatepe H.O., et al. The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis. Pediatr Surg Int 2014, 30(3):327-332.
-
(2014)
Pediatr Surg Int
, vol.30
, Issue.3
, pp. 327-332
-
-
Karatepe, H.O.1
-
59
-
-
37649028033
-
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
-
Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Syst Rev 2006, (3):CD004454.
-
(2006)
Cochrane Syst Rev
, Issue.3
, pp. CD004454
-
-
Roberts, D.1
Dalziel, S.2
-
60
-
-
38349125416
-
Localization and control of expression of VEGF-A and the VEGFR-2 receptor in fetal sheep intestines
-
Holmes K., et al. Localization and control of expression of VEGF-A and the VEGFR-2 receptor in fetal sheep intestines. Pediatr Res 2008, 63(2):143-148.
-
(2008)
Pediatr Res
, vol.63
, Issue.2
, pp. 143-148
-
-
Holmes, K.1
-
61
-
-
0037967272
-
Tumorigenesis and the angiogenic switch
-
Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3(6):401-410.
-
(2003)
Nat Rev Cancer
, vol.3
, Issue.6
, pp. 401-410
-
-
Bergers, G.1
Benjamin, L.E.2
-
63
-
-
84921288113
-
Effects of tumor microenvironmental factors on VEGF expression
-
Wang F., et al. Effects of tumor microenvironmental factors on VEGF expression. Biomed Rep 2013, 1(4):539-544.
-
(2013)
Biomed Rep
, vol.1
, Issue.4
, pp. 539-544
-
-
Wang, F.1
-
64
-
-
0037141345
-
Intra-tumoural microvessel density in human solid tumours
-
Hasan J., Byers R., Jayson G.C. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002, 86(10):1566-1577.
-
(2002)
Br J Cancer
, vol.86
, Issue.10
, pp. 1566-1577
-
-
Hasan, J.1
Byers, R.2
Jayson, G.C.3
-
65
-
-
0032714311
-
KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells
-
Yoshiji H., et al. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells. Hepatology 1999, 30(5):1179-1186.
-
(1999)
Hepatology
, vol.30
, Issue.5
, pp. 1179-1186
-
-
Yoshiji, H.1
-
66
-
-
84899026220
-
Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents
-
Vano Y.A., et al. Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents. Exp Rev Anticancer Ther 2014.
-
(2014)
Exp Rev Anticancer Ther
-
-
Vano, Y.A.1
-
67
-
-
0033830523
-
Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature
-
Grunstein J., et al. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol 2000, 20(19):7282-7291.
-
(2000)
Mol Cell Biol
, vol.20
, Issue.19
, pp. 7282-7291
-
-
Grunstein, J.1
-
68
-
-
0034129125
-
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo
-
Zhang H.T., et al. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 2000, 83(1):63-68.
-
(2000)
Br J Cancer
, vol.83
, Issue.1
, pp. 63-68
-
-
Zhang, H.T.1
-
69
-
-
0000391746
-
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
-
Bergers G., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2(10):737-744.
-
(2000)
Nat Cell Biol
, vol.2
, Issue.10
, pp. 737-744
-
-
Bergers, G.1
-
70
-
-
84890075029
-
Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors
-
Ferrero E., et al. Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors. Biomed Res Int 2013, 2013:545983.
-
(2013)
Biomed Res Int
, vol.2013
, pp. 545983
-
-
Ferrero, E.1
-
71
-
-
0036009760
-
VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding
-
Soker S., et al. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem 2002, 85(2):357-368.
-
(2002)
J Cell Biochem
, vol.85
, Issue.2
, pp. 357-368
-
-
Soker, S.1
-
72
-
-
0034612203
-
Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor
-
Baumgartner I., et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Int Med 2000, 132(11):880-884.
-
(2000)
Ann Int Med
, vol.132
, Issue.11
, pp. 880-884
-
-
Baumgartner, I.1
-
73
-
-
0037453099
-
The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis
-
Henry T.D., et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003, 107(10):1359-1365.
-
(2003)
Circulation
, vol.107
, Issue.10
, pp. 1359-1365
-
-
Henry, T.D.1
-
74
-
-
0037370325
-
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
-
Eremina V., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111(5):707-716.
-
(2003)
J Clin Invest
, vol.111
, Issue.5
, pp. 707-716
-
-
Eremina, V.1
-
75
-
-
1542297332
-
Pathogenesis of lesions in late age-related macular disease
-
Holz F.G., et al. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004, 137(3):504-510.
-
(2004)
Am J Ophthalmol
, vol.137
, Issue.3
, pp. 504-510
-
-
Holz, F.G.1
-
76
-
-
33646816714
-
Neovascularization in human atherosclerosis
-
Moreno P.R., et al. Neovascularization in human atherosclerosis. Circulation 2006, 113(18):2245-2252.
-
(2006)
Circulation
, vol.113
, Issue.18
, pp. 2245-2252
-
-
Moreno, P.R.1
-
78
-
-
84884808814
-
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
-
Weidemann A.K., et al. Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin, Cosmet Invest Dermatol 2013, 6:233-244.
-
(2013)
Clin, Cosmet Invest Dermatol
, vol.6
, pp. 233-244
-
-
Weidemann, A.K.1
-
79
-
-
0036068479
-
The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis
-
Afuwape A.O., Kiriakidis S., Paleolog E.M. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol 2002, 17(3):961-972.
-
(2002)
Histol Histopathol
, vol.17
, Issue.3
, pp. 961-972
-
-
Afuwape, A.O.1
Kiriakidis, S.2
Paleolog, E.M.3
-
80
-
-
0031837973
-
Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease
-
Griga T., et al. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 1998, 33(5):504-508.
-
(1998)
Scand J Gastroenterol
, vol.33
, Issue.5
, pp. 504-508
-
-
Griga, T.1
-
81
-
-
0036216571
-
Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease
-
Griga T., et al. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 2002, 49(43):116-123.
-
(2002)
Hepatogastroenterology
, vol.49
, Issue.43
, pp. 116-123
-
-
Griga, T.1
-
82
-
-
33847016462
-
Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha
-
Stannard A.K., et al. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 2007, 27(3):494-502.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, Issue.3
, pp. 494-502
-
-
Stannard, A.K.1
-
83
-
-
84898543443
-
Integrated effects of matrix mechanics and vascular endothelial growth factor (VEGF) on capillary sprouting
-
Wu Y., Al-Ameen M.A., Ghosh G. Integrated effects of matrix mechanics and vascular endothelial growth factor (VEGF) on capillary sprouting. Ann Biomed Eng 2014.
-
(2014)
Ann Biomed Eng
-
-
Wu, Y.1
Al-Ameen, M.A.2
Ghosh, G.3
-
84
-
-
84894256030
-
Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing
-
Martino M.M., et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 2014, 343(6173):885-888.
-
(2014)
Science
, vol.343
, Issue.6173
, pp. 885-888
-
-
Martino, M.M.1
-
85
-
-
70349850473
-
Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle
-
Deasy B.M., et al. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther: J Am Soc Gene Ther 2009, 17(10):1788-1798.
-
(2009)
Mol Ther: J Am Soc Gene Ther
, vol.17
, Issue.10
, pp. 1788-1798
-
-
Deasy, B.M.1
-
86
-
-
33751210105
-
VEGF at the neurovascular interface: therapeutic implications for motor neuron disease
-
Lambrechts D., Carmeliet P. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta 2006, 1762(11-12):1109-1121.
-
(2006)
Biochim Biophys Acta
, vol.1762
, Issue.11-12
, pp. 1109-1121
-
-
Lambrechts, D.1
Carmeliet, P.2
-
87
-
-
57349177854
-
VEGF is critical for stem cell-mediated cardio protection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function
-
Markel T.A., et al. VEGF is critical for stem cell-mediated cardio protection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol. Heart Circ Physiol 2008, 295(6):H2308-H2314.
-
(2008)
Am J Physiol. Heart Circ Physiol
, vol.295
, Issue.6
, pp. H2308-H2314
-
-
Markel, T.A.1
-
88
-
-
0032853603
-
Vascular endothelial growth factor and diabetes - the agonist versus antagonist paradox
-
Duh E., Aiello L.P. Vascular endothelial growth factor and diabetes - the agonist versus antagonist paradox. Diabetes 1999, 48(10):1899-1906.
-
(1999)
Diabetes
, vol.48
, Issue.10
, pp. 1899-1906
-
-
Duh, E.1
Aiello, L.P.2
-
89
-
-
0032710319
-
Clinical applications of angiogenic growth factors and their inhibitors
-
Ferrara N., Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999, 5(12):1359-1364.
-
(1999)
Nat Med
, vol.5
, Issue.12
, pp. 1359-1364
-
-
Ferrara, N.1
Alitalo, K.2
-
90
-
-
84908658539
-
Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats
-
Chaudagar K.K., Mehta A.A. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats. Clin Exp Hypertens 2014, 15-16.
-
(2014)
Clin Exp Hypertens
, pp. 15-16
-
-
Chaudagar, K.K.1
Mehta, A.A.2
-
91
-
-
84888043127
-
Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart
-
Ishimaru K., et al. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart. J Thoracic Cardiovasc Surg 2013, 146(6):1516-1525.
-
(2013)
J Thoracic Cardiovasc Surg
, vol.146
, Issue.6
, pp. 1516-1525
-
-
Ishimaru, K.1
-
92
-
-
84890620046
-
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia
-
Lee H.J., et al. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia. Yonsei Med J 2014, 55(1):99-106.
-
(2014)
Yonsei Med J
, vol.55
, Issue.1
, pp. 99-106
-
-
Lee, H.J.1
-
93
-
-
0037423321
-
Angiogenesis-independent endothelial protection of liver: role of VEGFR-1
-
LeCouter J., et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003, 299(5608):890-893.
-
(2003)
Science
, vol.299
, Issue.5608
, pp. 890-893
-
-
LeCouter, J.1
-
94
-
-
0036665610
-
Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study
-
Makinen K., et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther: J Am Soc Gene Ther 2002, 6(1):127-133.
-
(2002)
Mol Ther: J Am Soc Gene Ther
, vol.6
, Issue.1
, pp. 127-133
-
-
Makinen, K.1
-
95
-
-
0038644624
-
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
-
Xia Y.P., et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003, 102(1):161-168.
-
(2003)
Blood
, vol.102
, Issue.1
, pp. 161-168
-
-
Xia, Y.P.1
-
97
-
-
84921282728
-
-
Vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), hepatocyte growth factor (HGF) in patients with acute coronary syndrome (ACS). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US). [cited 2014 Aug 1].
-
Institute of Cardiology, Warsaw, Poland. Vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), hepatocyte growth factor (HGF) in patients with acute coronary syndrome (ACS). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US). 2000 [cited 2014 Aug 1]. http://clinicaltrials.gov/.
-
(2000)
-
-
-
98
-
-
67649236985
-
Effect of cardiac rehabilitation on angiogenic cytokines in postinfarction patients
-
Lee B.C., et al. Effect of cardiac rehabilitation on angiogenic cytokines in postinfarction patients. Heart 2009, 95(12):1012-1018.
-
(2009)
Heart
, vol.95
, Issue.12
, pp. 1012-1018
-
-
Lee, B.C.1
-
99
-
-
84873208224
-
Concentration of vascular endothelial growth factor in patients with acute coronary syndrome
-
Konopka A., et al. Concentration of vascular endothelial growth factor in patients with acute coronary syndrome. Cytokine 2013, 61(2):664-669.
-
(2013)
Cytokine
, vol.61
, Issue.2
, pp. 664-669
-
-
Konopka, A.1
-
100
-
-
84921261074
-
-
Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy (THEANGIOGEN). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
-
Instituto de Cardiologia do Rio Grande do Sul. Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy (THEANGIOGEN). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov/.
-
(2000)
-
-
-
101
-
-
84921286834
-
-
NOGA angiogenesis revascularization therapy: evaluation by radionuclide imaging - the northern trial. In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
-
St. Michael's Hospital, Toronto. NOGA angiogenesis revascularization therapy: evaluation by radionuclide imaging - the northern trial. In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov.
-
(2000)
-
-
-
102
-
-
84921317685
-
-
Angiogenesis using VEGF-A165/bFGF plasmid delivered percutaneously in no-option CAD patients; a controlled trial (VIF-CAD). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 Aug 1].
-
Institute of Cardiology, Warsaw, Poland. Angiogenesis using VEGF-A165/bFGF plasmid delivered percutaneously in no-option CAD patients; a controlled trial (VIF-CAD). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 Aug 1]. http://clinicaltrials.gov.
-
(2000)
-
-
-
103
-
-
84885131010
-
High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease
-
Giusti I.I., et al. High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease. Hum Gene Ther Methods 2013, 24(5):298-306.
-
(2013)
Hum Gene Ther Methods
, vol.24
, Issue.5
, pp. 298-306
-
-
Giusti, I.I.1
-
104
-
-
79952447660
-
Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)
-
Kukula K., et al. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD). Am Heart J 2011, 161(3):581-589.
-
(2011)
Am Heart J
, vol.161
, Issue.3
, pp. 581-589
-
-
Kukula, K.1
-
105
-
-
84921303616
-
-
Kasiak Research Pvt. Ltd. To evaluate the safety and efficacy of IM and IV administration of autologous ADMSC's for treatment of CLI. In: ClinicalTrials.gov [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
-
Kasiak Research Pvt. Ltd., Kasiak Research Pvt. Ltd. To evaluate the safety and efficacy of IM and IV administration of autologous ADMSC's for treatment of CLI. In: ClinicalTrials.gov [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov/.
-
(2000)
-
-
-
106
-
-
84921266475
-
-
Northwestern University. VEGF gene transfer for critical limb ischemia. In: ClinicalTrials.gov [Internet] Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
-
Douglas Losordo MD. Northwestern University. VEGF gene transfer for critical limb ischemia. In: ClinicalTrials.gov [Internet] Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov/.
-
(2000)
-
-
|